To further verify the regulation of FOXO1 expression by EZH2, we treated C4-2 and 22Rv1 cell lines with histone deacetylase (HDAC) inhibitor SAHA, an FDA approved drug for cancer treatment. Here, HDAC9 is linked to cancer.